TATA-box-binding protein-associated factor 15 is a novel biomarker that promotes cell proliferation and migration in gastrointestinal stromal tumor

Table 3 Correlation between the expression of TATA-box-binding protein-associated factor 15 and clinicopathological characteristics in gastrointestinal stromal tumors

Characteristics	TAF15 expression		P value
	Negative	Positive
Total number	31	130
Sex			0.2730a
Male	16 (9.9)	53 (32.9)
Female	15 (9.3)	77 (58.7)
Age in yr			0.8228a
≤ 60	15 (9.3)	60 (37.2)
> 60	16 (9.9)	70 (43.5)
Tumor size
Maximum diameter in cm
≤ 5	29 (18.0)	74 (46.0)	0.0001a
> 5	2 (1.2)	56 (34.8)
GIST risk stage			0.0021b
Very low risk	15 (9.3)	30 (18.6)
Low risk	11 (6.8)	31 (19.3)
Intermediate risk	3 (1.9)	29 (18.0)
High risk	2 (1.2)	40 (24.8)
Metastasis			0.1316a
-	31 (19.3)	121 (75.2)
+	0 (0.0)	9 (5.6)

^aP values were calculated by χ² test.

^bP values were calculated by Mann-Whitney U test.

Total patients of 161. Data are presented as n(%). TAF15: TATA-box-binding protein-associated factor 15; GIST: Gastrointestinal stromal tumor.